Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Smackover Lithium, a partnership between Standard Lithium Ltd. (NYSE American: SLI) and Equinor, released a positive Preliminary Economic Assessment (PEA) for the Franklin lithium brine project in East Texas. The PEA highlights impressive economics with an after-tax NPV8 of $5.0 billion, IRR of 24%, and annual production capacity up to 70,000 tonne…
AsiaStrategy has entered into a significant Bitcoin-collateralised credit facility with a leading institutional partner in Asia, adding recurring revenue to its pledging business and enhancing its digital asset treasury operations. The company plans to grow this lending business, explore new collateral types and lending structures, and pursue acqui…
MediciNova, a clinical-stage biopharmaceutical company listed on NASDAQ (MNOV), announced participation in the H.C. Wainwright and ROTH Capital healthcare conferences in September. Management will discuss progress on their late-stage pipeline, including upcoming topline readouts from Phase 2 and Phase 3 studies involving MN-001 and MN-166 compounds…
Roivant Sciences announced highly positive Phase 2 trial results for mosliciguat, showing the largest-ever reduction in pulmonary vascular resistance in a randomized controlled pulmonary hypertension trial. Mosliciguat demonstrated significant improvements in six-minute walk distance and cardiac biomarker levels, alongside a favorable safety profil…
Belite Bio submitted a New Drug Application for tinlarebant to Japan's Ministry of Health under the expedited Sakigake designation for Stargardt disease type 1, a rare inherited retinal disorder. The drug is also under Priority Review by the U.S. FDA with a target action date in early 2027. If approved, tinlarebant would be the first therapy availa…
Sandisk's rapid pivot into data-center NAND has produced outsized free cash flow and eye-popping margins. With $11.494B in trailing free cash flow, a market cap near $255B and strong contractual revenue visibility, this is a trade that prioritizes cash generation over forecasting complex supply cycles. I recommend a long entry at $1740 with a $1600…
Dyne Therapeutics' stock plunged 31.0% in pre-market trading to $16.76, a fall that market participants usually associate with a material, company-specific development. The move comes as the firm approaches high-stakes regulatory and clinical readouts for its lead programs and after a recent quarterly loss wider than analysts expected.
Satellogic, a NASDAQ-listed company specializing in Persistent Global Intelligence infrastructure, has appointed Vice Admiral (Ret.) Frank D. "Trey" Whitworth as President. Whitworth brings extensive leadership experience from his 36-year career in U.S. defense and intelligence agencies, including as NGA Director. His role will focus on integrating…
Lithia & Driveway (NYSE: LAD) has acquired Rockwall Hyundai in Texas, adding approximately $75 million in annualized revenue and strengthening its presence in the Dallas-Fort Worth market. The acquisition increases year-to-date expected annualized revenue acquired to $915 million. Additionally, the company updated its share repurchase program, havi…
Microchip (MCHP) looks cheaper than the headline P/E implies. The company’s Data Center Solutions unit is scaling fast, automotive and industrial demand remain durable, and free cash flow of nearly $1.0B gives the firm optionality to protect margins and return capital. This trade idea buys a corrective pullback around current levels with a clear st…
SoFi posted another quarter of rapid growth — 40% revenue expansion, stronger cross-sell and rising paid subscriptions — yet the stock is down on profit guidance noise. I view the selloff as an opportunity to buy a company that is increasingly monetizing non-lending products and building a durable customer flywheel. This is a mid-term swing trade w…
Star Bulk Carriers Corp., a Nasdaq-listed maritime shipping company, announced the price range for its equity offering in Greece of up to 4,400,000 new common shares. The offering price range is set between €23.00 and €25.50, equivalent to approximately $26.75 to $29.66 USD. The shares will be offered to non-U.S. persons outside the United States u…
India's aggregate fuel consumption in August fell 2.8% from the same month in 2025, with total usage reaching 18.61 million metric tons, according to data from the Petroleum Planning and Analysis Cell of the oil ministry. The month saw gains in gasoline and diesel volumes, contrasted with notable declines in liquefied petroleum gas and naphtha, whi…
Credo (CRDO) remains one of the most direct plays on AI data-center connectivity. Q1 FY2027 revenue of $479M (up 114.7% YoY) and management's $600M+ optical revenue target show product-led growth, but the stock has been swept lower by margin pressure and headline-driven selling. We like a disciplined long: enter at $150.00, stop at $125.00, target …
Himax Technologies announced the release of its HX83196/HX83197 series automotive TDDI chips featuring high-speed embedded DisplayPort (eDP) interface for enhanced smart car displays. These new chips integrate touch, display driver, and high-bandwidth eDP transmission into a single solution, supporting larger sizes and higher resolutions with impro…
Bombardier (BDRBF) looks positioned for another growth leg. Recent actions - settling a New York bondholder lawsuit, redeeming large tranches of near-term notes, and expanding service capabilities in London - reduce near-term overhangs and lengthen the runway for recurring services revenue. At a market cap of $22.61B and a PE of 23.7, the stock is …
ExxonMobil ($162.40) looks attractive as a dividend-bearing, cash-flow-rich integrated oil major, but the trade is conditional: buy only if you expect a sustained 'war premium' to keep crude prices elevated. This plan gives an entry at $161.02, a stop at $152.00, and a primary target at $170.00 with a stretch target at $176.41, framed across short,…
Russian forces renewed an aerial campaign on Kyiv early Tuesday following a short pause coinciding with the departure of U.S. peace envoys, killing two people and injuring at least 10. The assault sparked fires and damaged multiple residential and public buildings, while Poland launched preventive air operations and a Russian region reported injuri…
KBR is trading at a reasonable valuation after a pullback tied to near-term revenue softness. Behind that noise are a record sustainable-tech backlog (~$5.5B) and an expanding Mission Technology pipeline that will be spun out as Trinzic in Jan 2027. This trade targets a mid-term re-rating as backlog converts and spin-related clarity hits the market…
Nano Labs has real operational catalysts - a hardware product push, an AI/agent-cloud MoU, and a CEO who bought shares - but H1 2026 crypto-related fair-value losses and razor-thin revenue leave the company dependent on asset-price recovery and execution. For traders willing to take risk, there's a defined swing-long setup that targets a meaningful…
Verisk Analytics has introduced Fraud Discovery, an integrated fraud prevention platform combining intelligence, analytics, network analysis, digital forensics, and case management. The platform aims to help insurers detect and combat increasingly sophisticated and organized fraud schemes by uncovering hidden relationships and prioritizing investig…
Upstream Bio announced positive results from the Phase 2 VALIANT trial of verekitug, a novel TSLP receptor antagonist, demonstrating a 56% reduction in annualized asthma exacerbation rate compared to placebo in severe asthma patients. Verekitug also improved lung function and inflammatory biomarkers with favorable safety. The company plans to start…
Goldman Sachs has lifted its Brent and WTI price forecasts by $5 per barrel, citing expectations that shipping disruptions in the Middle East will continue into 2027. The bank's strategists, led by Daan Struyven, elevated forecasts to $85 for Brent and $80 for WTI for December 2026, and to $80/75 for Brent/WTI in 2027. Despite the upgrade, the team…
Natural Resource Partners (NRP) is trading at roughly a 10.6% free cash flow yield on reported trailing FCF, with management signaling a distribution increase in November. With debt down materially, a stable mineral-royalty cash stream, and meaningful FCF per share, this is a long trade aimed at capturing both a distribution rerating and continued …
Oil prices continued to rise on Tuesday, with Brent crude holding above $97 a barrel and U.S. WTI advancing strongly, after Iranian officials warned that oil and gas infrastructure in the Gulf could be subject to retaliation. Statements from Iranian leaders about a potential maritime exclusion zone and alternative shipping corridors have intensifie…
